The rapid development and deployment of COVID-19 vaccines has been one of the greatest achievements of the pandemic.

However, Australia risks relying on COVID-19 vaccines from two main companies — Pfizer and Moderna — and that’s a problem.

While the need for COVID-19 vaccines is not going away anytime soon, we need to shape the market to drive more competition for better access to improved vaccines.

Here’s what Australia needs to do to break free from an effective duopoly dominating the local market, especially when many of us are likely to need boosters.